The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Scientists have linked sleeping for less than seven hours to a 7% increased risk of developing high blood pressure over time, ...

US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...

FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

Sleep breathing problems, like sleep apnea, may lead to changes in the hippocampus and white matter, impacting brain health ...

People with breathing problems during sleep may have a larger hippocampus, the area of the brain responsible for memory and ...

An estimated 39 million American adults suffer from obstructive sleep apnea, a condition in which the upper airway is blocked ...

Sleep disordered breathing is a range of conditions that cause abnormal breathing during sleep including snoring and ...

The Food and Drug Administration has approved Zepbound to treat obstructive sleep apnea for people who are moderately or ...

Sleep apnea is a condition in which breathing stops intermittently while a person sleeps. Read more at straitstimes.com.

Even before the FDA approval, some doctors have been prescribing weight-loss drugs to people with sleep apnea.